1. (1) Under Subsection 58-1-203(1)(f) and Section R156-1-205, there is created the Advisory Pharmacy Compounding Education Committee (Committee).

2. (2) The Committee shall consist of seven members, diversified between:

   1. (a) retail pharmacy;
   2. (b) hospital pharmacy;
   3. (c) other pharmacy specialties determined pertinent by the Division in collaboration with the Board; and
   4. (d) at least one physician.

3. (3) Each Committee member shall:

   1. (a) be licensed in good standing with the state; and
   2. (b) have experience and knowledge of least one USP Chapter, USP <795>, USP <797>, or USP <800>.
4. (4) The Board shall nominate Committee members for appointment in accordance with Section R156-1-205, and if possible at least six months before the date of cessation of service.

5. (5) The Committee's duties and responsibilities shall be to address pharmacy compounding issues, including:

   1. (a) monitoring current and proposed federal standards and USP standards for pharmacy compounding; and

   2. (b) reviewing and making recommendations to the Division and boards regarding:

      1. (i) pharmacy compounding education and training;
      2. (ii) pharmacy compounding laws and rules; and
      3. (iii) other pharmacy compounding issues as assigned by the Division in collaboration with the Board.
6. (6) The Committee shall meet at least once per calendar quarter, and as may be directed by the Board with the concurrence of the Division.
7. (7) The Committee shall annually designate one of its members to act as chair and another member to act as vice chair, on a calendar year basis. The Committee shall elect its chair and vice chair at a meeting conducted in the last quarter of the calendar year.
8. (8) Each calendar quarter, a Committee designee shall attend at least one meeting of the Board and one meeting of the Medical Licensing Board to report the Committee's activities and recommendations to each board.

KEY: pharmacists, licensing, pharmacies

Date of Last Change: August 8, 2025

Notice of Continuation: August 5, 2024

Authorizing, and Implemented or Interpreted Law: 63G-3-201; 58-17b-101; 58-17b-601(1); 58-37-1; 58-1-106(1)(a); 58-1-202(1)(a)